|
Volumn 7, Issue 14 SUPPL. SEPTEMBER, 2001, Pages
|
Managing dry eyes and dry mouth in Sjögren's syndrome
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANALGESIC AGENT;
ANTIDEPRESSANT AGENT;
ANTIHISTAMINIC AGENT;
ANTIHYPERTENSIVE AGENT;
ANTIINFLAMMATORY AGENT;
CEVIMELINE;
CYCLOSPORIN;
IMMUNOSUPPRESSIVE AGENT;
MUSCARINIC AGENT;
PILOCARPINE;
AUTOIMMUNE DISEASE;
CLINICAL FEATURE;
DAILY LIFE ACTIVITY;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC PROCEDURE;
DIFFERENTIAL DIAGNOSIS;
DISEASE COURSE;
DISEASE SEVERITY;
DOSE RESPONSE;
DRY EYE;
GOOD CLINICAL PRACTICE;
HEALTH CARE COST;
HEALTH CARE DELIVERY;
HEALTH ECONOMICS;
HEALTH MAINTENANCE ORGANIZATION;
HIGH RISK PATIENT;
HUMAN;
INTERVIEW;
MALIGNANT TRANSFORMATION;
MANAGED CARE ORGANIZATION;
MEDICAL LITERATURE;
MEDICAL RESEARCH;
MEDICAL SPECIALIST;
NOTE;
PATIENT REFERRAL;
PRACTICE GUIDELINE;
PRESCRIPTION;
PREVALENCE;
PRIMARY HEALTH CARE;
PRIORITY JOURNAL;
PROGNOSIS;
QUALITY OF LIFE;
SEX DIFFERENCE;
SJOEGREN SYNDROME;
SYMPTOMATOLOGY;
TREATMENT OUTCOME;
UNITED STATES;
XEROSTOMIA;
EYE;
HUMANS;
MOUTH;
PREVALENCE;
PROGNOSIS;
SALIVA;
SALIVARY GLANDS;
SJOGREN'S SYNDROME;
UNITED STATES;
|
EID: 0034759354
PISSN: 10880224
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (6)
|
References (0)
|